The Impact of Targeted Estrogen Receptor (ER) Imaging on Breast Cancer Patients

October 19, 2022

Leading healthcare experts Dr. Hannah Linden and Dr. Gary Ulaner will offer their insights about a diagnostic imaging agent that may help inform physicians clinical decisions and treatment selection for people with recurrent or metastatic breast cancer.

Key takeaways from webinar viewers:

  • FES PET scan better than FDG PET to diagnose metastatic diseases.
  • Helpful tool to determine best treatment at the time of metastatic diagnosis or when there’s progression.
  • More targeted scan will ensure more personalized care in hopes of longer survival.

National Helpline: